Valproate, serum
Clinical Background:
Valproate has a different spectrum of anticonvulsant activity to the other commonly used anticonvulsants, and it is the drug of choice for the treatment of myoclonic seizures and generalised absenc...
Valproate has a different spectrum of anticonvulsant activity to the other commonly used anticonvulsants, and it is the drug of choice for the treatment of myoclonic seizures and generalised absence seizures because of its minimal sedative action and absence of CNS side effects.It is also effective in general and partial epilepsy and has been used in the prophylaxis of febrile convulsions.
Valproate is an effective option in the therapy of bipolar affective disorder.
Test Details
-
Discipline:
Biochemistry
Biochemistry
-
Specimen Container Adult:
Serum (SST or plain tube)
Serum (SST or plain tube)
-
Specimen Container Paediatric:
Serum (SST or plain tube)
Serum (SST or plain tube)
-
Minimum Volume Adult:
1 mL
1 mL
-
Minimum Volume Paediatric:
0.5 mL
0.5 mL
-
Special Requirement:
Trough sample required
Trough sample required
-
Sample Stability:
Unseparated sample: 2 days
Separated sample: 2 days at 15-25°C, 2 days at 2-4°C, 3 months at -20°CUnseparated sample: 2 days
Separated sample: 2 days at 15-25°C, 2 days at 2-4°C, 3 months at -20°C -
Interpretation:
Monitoring therapy
Pharmacokinetic studies indicate a poor relationship with pharmacodynamics.
Most authorities agree routine monitoring is not necessary
Monitoring is found useful when compliance ...Read MoreMonitoring therapy
Pharmacokinetic studies indicate a poor relationship with pharmacodynamics.
Most authorities agree routine monitoring is not necessary
Monitoring is found useful when compliance is an issue
Little hard evidence for a therapeutic valproate range though 50 – 100mg/L is often quoted. It is clear that some patients are well controlled with concentrations well below 50mg/L and others may require well in excess of 100mg/L.
Toxicity
Important side effects include weight gain, paediatric hepatotoxicity and hyperammonaemia. There is also a possible teratogenic effect. -
Reference Ranges:
Therapeutic Range 50 - 100 mg/L
Therapeutic Range 50 - 100 mg/L
-
Other Info:
Lithium heparin plasma samples also acceptable
Lithium heparin plasma samples also acceptable
-
Routine Contact Name:
Duty Biochemist
-
Routine Telephone:
Freeman: 0191 244 8889
RVI: 0191 282 9719Freeman: 0191 244 8889
RVI: 0191 282 9719 -
Routine Email: